Samson Rock Capital LLP Repligen Corp Transaction History

Samson Rock Capital LLP

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 08, 2022	SELL	$247.59 - $304.47 $1.66 Million - $2.04 Million	-6,686 Closed	0 $0
Q3 2021 Oct 18, 2021	BUY	$194.77 - $324.21 $1.3 Million - $2.17 Million	6,686 New	6,686 $1.93 Million

522

53.2M

1.05M

228K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.7B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Samson Rock Capital LLP, based on Form 13F filings with the SEC.

Stay updated on Samson Rock Capital LLP with notifications on news.